Neonatal hypoxia-ischemia differentially upregulates MAGUKs and associated proteins in PSD-93-deficient mouse brain

Xiangning Jiang1, Dezhi Mu, R Ann Sheldon

  • 1Department of Neurology, University of California, San Francisco 94143-0663, USA.

Stroke
|November 8, 2003
PubMed
Abstract

Insights

Deleting PSD-93 (postsynaptic density-93) did not protect against neonatal brain injury, possibly due to PSD-95 (postsynaptic density-95) upregulation. These MAGUKs may compensate for each other.

Area of Science:

  • Neuroscience
  • Synaptic Plasticity
  • Neuroprotection

Background:

  • Postsynaptic density (PSD)-93 and PSD-95 are key membrane-associated guanylate kinases (MAGUKs) in excitatory synapses.
  • These proteins link N-methyl-d-aspartate receptors (NMDARs) with neuronal nitric oxide synthase (nNOS), impacting cell death after neonatal hypoxia-ischemia (HI).

Purpose of the Study:

  • To investigate if PSD-93 deletion dissociates NMDAR from nNOS.
  • To determine if PSD-93 knockout confers neuroprotection against neonatal HI.

Main Methods:

  • Utilized PSD-93 knockout (PSD-93-/-) and wild-type (+/+) mice subjected to neonatal HI.
  • Assessed brain damage using cresyl violet and iron stains.
  • Employed Western blot and coimmunoprecipitation to analyze protein expression and interactions.

Main Results:

  • No significant difference in mortality or brain injury between PSD-93-/- and +/+ mice.
  • PSD-95 maintained interaction with NR2B and nNOS in PSD-93 deficient mice.
  • Post-HI, PSD-93-/- mice showed increased PSD-95, nNOS, and NR2A expression compared to controls, with preserved NR2A/NR2B levels.

Conclusions:

  • PSD-93 is not essential for baseline synaptic function but may regulate NMDAR signaling post-HI.
  • PSD-93 deletion alone does not provide neuroprotection, potentially due to PSD-95 upregulation.
  • MAGUKs may exhibit functional redundancy, ensuring normal NMDAR function postnatally.

Related Concept Videos